https://www.selleckchem.com/products/kpt-330.html
3 for Lumipulse Aβ42/p-tau181. The Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology. The Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology. Numerous neuroimaging studies demonstrated an association between the apolipoprotein E (APOE) 4 allele and resting-state functional connectivity (rsFC) of regions within the default mode network (DMN), both in healt
Like
Comment
Share
